Ischemic stroke, susceptibility to
OMIM:601367 Mode of inheritance:Multifactorial
Disease classification:Diseases of the circulatory system
Polymorphisms
| Gene symbol | F2 |
|---|
| Reference transcript | NM_000506.3 |
|---|
| DNA Change | c.*97G>A |
|---|
| A.A. Change | |
|---|
| Exon/Intron | 3' of the stop codon |
|---|
| Variation Type | substitution |
|---|
| Reference SNP | rs1799963 |
|---|
| Cases | 91 patients |
|---|
| Controls | 182 healthy controls |
|---|
| Frequency | | Allele/Genotype | Frequency in cases | Frequency in controls | OR (95%CI) | P-value |
|---|
| G | 94% | 97,3% | 1 | | | A | 6% | 2.7% | 2.3(0.58-8.9) | | | GG | 87,9% | 94,5% | 1 | | | GA | 12.1% | 5.5% | 2.3(0.97-5.7) | 0.054 | | AA | 0 | 0 | | |
|
|---|
| Comments | No significant association was found between F2-G20210A polymorphism with stroke, |
|---|
| Reference | They-They TP, Battas O, Slassi I, Rafai MA, Katumbay DT, Nadifi S.
Prothrombin G20210A and factor V Leiden polymorphisms in stroke. J Mol Neurosci. 2012 Jan;46(1):210-6. |
|---|
| Gene symbol | MTHFR |
|---|
| Reference transcript | NM_005957.4 |
|---|
| DNA Change | c.665C>T |
|---|
| A.A. Change | p.Ala222Val |
|---|
| Exon/Intron | exon 4 |
|---|
| Variation Type | substitution |
|---|
| Reference SNP | rs1801133 |
|---|
| Cases | 42 Atherothrombotic |
|---|
| Controls | 182 healthy controls |
|---|
| Frequency | | Allele/Genotype | Frequency in cases | Frequency in controls | OR (95%CI) | P-value |
|---|
| C | 0.44 | 0.27 | 2.16 (1.17-3.8) | 0.012 | | T | 0.56 | 0.73 | | | | TT/CTvsCC | 28 (66.7%) | 87 (47.8%) | 2.2 (1.08-4.4) | 0.030 | | TT vs CC | 9 (39.1%) | 11 (10.4%) | 5.5 (1.95-15.8) | 0.001 | | CT vs CC | 19 (57.6%) | 76 (44.4%) | 1.69 (0.8-3.6) | 0.169 |
|
|---|
| Comments | The results shown statistically significant association of T allele carriers genetic factors with atherothrombotic, |
|---|
| Reference | They-They TP, Nadifi S, Rafai MA, Battas O, Slassi I.
Methylenehydrofolate reductase (C677T) polymorphism and large artery ischemic stroke subtypes. Acta Neurol Scand. 2011 Feb;123(2):105-10. |
|---|
| Gene symbol | NOS3 |
|---|
| Reference transcript | NM_000603.4 |
|---|
| DNA Change | c.894T>G |
|---|
| A.A. Change | p.Asp298Glu |
|---|
| Exon/Intron | exon 8 |
|---|
| Variation Type | substitution |
|---|
| Reference SNP | rs1799983 |
|---|
| Cases | 165 |
|---|
| Controls | 182 |
|---|
| Frequency | | Allele/Genotype | Frequency in cases | Frequency in controls | OR (95%CI) | P-value |
|---|
| G | 70.3% | 80.2% | 1 | | | T | 29.7% | 19.8% | 1.71 (1.21-2.43) | 0.003 | | GG | 50.3% | 64.3% | 1 | | | GT | 40.0% | 31.9% | 1.60 (1.02-2.52) | 0.040 | | TT | 8.0% | 3.8% | 3.22 (1.27-8.18) | 0.014 | | GT + TT | 46.7% | 35.7% | 1.78 (1.16-2.73) | 0.009 |
|
|---|
| Reference | Diakite B, Hamzi K, Slassi I, El Yahyaoui M, El Alaoui MM, Habbal R, Sellama N; GMRAVC.G894T endothelial nitric oxide synthase polymorphism and ischemic stroke in Morocco. Meta Gene. 2014 May 7;2:349-57. |
|---|
| Gene symbol | NOS3 |
|---|
| Reference transcript | NM_000603.4 |
|---|
| DNA Change | c.894T>G |
|---|
| A.A. Change | p.Asp298Glu |
|---|
| Exon/Intron | exon 8 |
|---|
| Variation Type | substitution |
|---|
| Reference SNP | rs1799983 |
|---|
| Cases | 118 MI patients |
|---|
| Controls | 184 healthy controls |
|---|
| Frequency | | Allele/Genotype | Frequency in cases | Frequency in controls | OR (95%CI) | P-value |
|---|
| T | 170 (72,03%) | 294 (79,89%) | 1 | | | G | 66 (27,97%) | 74 (20,11%) | 1.54 (1.06-2.23) | 0.001 | | TT | 60 (50,85%) | 116 (63,04%) | 1 | | | TG | 50 (42,37%) | 62 (33,69%) | 1,55 (0,97-2,48) | 0,02 | | GG | 8 (6,78%) | 6 (3,27%) | 2,57 (0,87-7,52) | 0,01 |
|
|---|
| Reference | Hassani Idrissi H, Hmimech W, Diakite B, Korchi F, Baghdadi D, Habbal R, Nadifi S.
Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco. Meta Gene. 2016 Apr 3;9:56-61. doi: 10.1016/j.mgene.2016.03.004. eCollection 2016. |
|---|
| Gene symbol | APOA5 |
|---|
| Reference transcript | NM_052968.4 |
|---|
| DNA Change | -1131T>C |
|---|
| A.A. Change | |
|---|
| Exon/Intron | 5' of the ATG codon |
|---|
| Variation Type | substitution |
|---|
| Reference SNP | rs662799 |
|---|
| Cases | 175 patients |
|---|
| Controls | 201 controls |
|---|
| Frequency | | Allele/Genotype | Frequency in cases | Frequency in controls | OR (95%CI) | P-value |
|---|
| T | 255 (72.9%) | 326 (81.1%) | 1 | | | C | 95 (27.1%) | 76 (18.9%) | 1.54 (1.01-2.33) | 0.007 | | TT | 99 (56.6%) | 134 (66.7%) | 1 | | | TC | 57 (32.6%) | 58 (28.8%) | 1.33 (0.85-2.08) | 0.212 | | CC | 19 (10.9%) | 9 (4.5%) | 2.86 (1.24-6.58) | 0.013 |
|
|---|
| Reference | Diakite B, Hamzi K, Hmimech W, Nadifi S; GMRAVC.
Genetic polymorphisms of T-1131C APOA5 and ALOX5AP SG13S114 with the susceptibility of ischaemic stroke in Morocco. J Genet. 2016 Jun;95(2):303-9. |
|---|
| Gene symbol | APOA5 |
|---|
| Reference transcript | NM_052968.4 |
|---|
| DNA Change | -1131T>C |
|---|
| A.A. Change | |
|---|
| Exon/Intron | 5' of the ATG codon |
|---|
| Variation Type | substitution |
|---|
| Reference SNP | rs662799 |
|---|
| Cases | 118 MI patients |
|---|
| Controls | 184 healthy controls |
|---|
| Frequency | | Allele/Genotype | Frequency in cases | Frequency in controls | OR (95%CI) | P-value |
|---|
| T | 137 (58,05%) | 262 (71,19%) | 1 | | | C | 99 (41,95%) | 106 (28,81%) | 1,78 (1,26-2,51) | 0.03 | | TT | 34 (28,81%) | 94 (51,08%) | 1 | | | TC | 69 (58,47%) | 74 (40,21%) | 2,57 (1,56-4,17) | 0,3 | | CC | 15 (12,72%) | 16 (8,71%) | 2,60 (1,18-5,66) | 0,03 |
|
|---|
| Reference | Hassani Idrissi H, Hmimech W, Diakite B, Korchi F, Baghdadi D, Habbal R, Nadifi S.
Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco. Meta Gene. 2016 Apr 3;9:56-61. doi: 10.1016/j.mgene.2016.03.004. eCollection 2016. |
|---|
| Gene symbol | ALOX5AP |
|---|
| Reference transcript | NM_001204406.1 |
|---|
| DNA Change | c.241+2284A>T (SG13S114) |
|---|
| A.A. Change | |
|---|
| Exon/Intron | intron 2 |
|---|
| Variation Type | substitution |
|---|
| Reference SNP | rs10507391 |
|---|
| Cases | 175 patients |
|---|
| Controls | 201 controls |
|---|
| Frequency | | Allele/Genotype | Frequency in cases | Frequency in controls | OR (95%CI) | P-value |
|---|
| A | 229 (65.4%) | 302 (75.1%) | 1 | | | T | 121 (34.6%) | 100 (24.9%) | 1.59 (1.16-2.19) | 0.004 | | AA | 89 (50.9%) | 119 (59.2%) | 1 | | | AT | 51 (29.1%) | 64 (31.8%) | 1.06 (0.67-1.68) | 0.786 | | TT | 35 (20.0%) | 18 (9.0%) | 2.57 (1.49-4.83) | 0.003 |
|
|---|
| Reference | Diakite B, Hamzi K, Hmimech W, Nadifi S; GMRAVC.
Genetic polymorphisms of T-1131C APOA5 and ALOX5AP SG13S114 with the susceptibility of ischaemic stroke in Morocco. J Genet. 2016 Jun;95(2):303-9. |
|---|
| Gene symbol | SERPINE1 |
|---|
| Reference transcript | NM_000602.4 |
|---|
| DNA Change | c.-820_-817G(4_5) |
|---|
| A.A. Change | |
|---|
| Exon/Intron | 5' of the ATG codon |
|---|
| Variation Type | indel |
|---|
| Reference SNP | rs587776796 |
|---|
| Cases | 118 MI patients |
|---|
| Controls | 184 healthy controls |
|---|
| Frequency | | Allele/Genotype | Frequency in cases | Frequency in controls | OR (95%CI) | P-value |
|---|
| 5G | 86 (36,45%) | 195 (52,98%) | 1 | | | 4G | 150 (63,55%) | 173 (47,02%) | 1,96 (1,4-2,72) | 0.03 | | 5G/5G | 9 (7,64%) | 73 (39,68%) | 1 | | | 4G/5G | 68 (57,62%) | 49 (26,63%) | 11,2 (8,3-15,08) | < 0.001 | | 4G/4G | 41 (34,74%) | 62 (33,69%) | 5,36 (3,8-7,2) | < 0.001 |
|
|---|
| Reference | Hassani Idrissi H, Hmimech W, Diakite B, Korchi F, Baghdadi D, Habbal R, Nadifi S.
Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco. Meta Gene. 2016 Apr 3;9:56-61. doi: 10.1016/j.mgene.2016.03.004. eCollection 2016. |
|---|